New EU rules for health technology assessments become effective
New EU rules for health technology assessments become effective
New EU rules for health technology assessments become effective
EudraVigilance eXtended Medicinal Product Dictionary (XEVMPD) - Authorisation status
Electronic submission of Article 57(2) data: questions and answers
Chapter 5: eXtended EudraVigilance Product Report Acknowledgement Message - Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA
Chapter 3.II: XEVPRM detailed user guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA
Committee for Advanced Therapies (CAT): 6-8 November 2024, European Medicines Agency, Amsterdam, the Netherlands, from 6 November 2024 to 8 November 2024
Minutes of the CHMP written procedure 19-22 August 2024
Human medicines European public assessment report (EPAR): Epixram, levetiracetam, Status: Application withdrawn
Second European Medicines Agency (EMA) and IPFA - PPTA global bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 12 November 2024
Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group